0.0759
price down icon4.29%   -0.0034
after-market After Hours: .07 -0.0059 -7.77%
loading
Onconetix Inc stock is traded at $0.0759, with a volume of 2.33M. It is down -4.29% in the last 24 hours and down -69.94% over the past month.
See More
Previous Close:
$0.0793
Open:
$0.0732
24h Volume:
2.33M
Relative Volume:
0.21
Market Cap:
$1.10M
Revenue:
-
Net Income/Loss:
$-53.12M
P/E Ratio:
-0.000698
EPS:
-108.8
Net Cash Flow:
$-15.86M
1W Performance:
-29.53%
1M Performance:
-69.94%
6M Performance:
-98.31%
1Y Performance:
-98.86%
1-Day Range:
Value
$0.067
$0.0759
1-Week Range:
Value
$0.065
$0.0999
52-Week Range:
Value
$0.065
$21.40

Onconetix Inc Stock (ONCO) Company Profile

Name
Name
Onconetix Inc
Name
Phone
513-620-4101
Name
Address
201 E. FIFTH STREET, CINCINNATI
Name
Employee
0
Name
Twitter
Name
Next Earnings Date
2024-05-30
Name
Latest SEC Filings
Name
ONCO's Discussions on Twitter

Compare ONCO with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
ONCO
Onconetix Inc
0.0759 1.10M 0 -53.12M -15.86M -108.80
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
484.01 124.29B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
610.64 68.39B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
590.06 35.99B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
262.16 33.93B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
264.32 28.47B 3.81B -644.79M -669.77M -6.24

Onconetix Inc Stock (ONCO) Latest News

pulisher
04:49 AM

Onconetix Appoints Karina Fedasz as Interim CEO - TipRanks

04:49 AM
pulisher
Apr 01, 2025

Onconetix Delays Yearly Report Filing - TipRanks

Apr 01, 2025
pulisher
Mar 27, 2025

Pre-market Movers: RGLS, SLNO, OCEA, OSRH... - RTTNews

Mar 27, 2025
pulisher
Mar 25, 2025

Onconetix claims validation of prostate cancer test Proclarix in Danish cohort - Yahoo Finance

Mar 25, 2025
pulisher
Mar 25, 2025

Onconetix Announces Successful Clinical Validation of its Innovative Prostate Cancer Test Proclarix in a Danish cohort - GlobeNewswire

Mar 25, 2025
pulisher
Mar 24, 2025

Onconetix reveals Proclarix’s clinical performance at EAU congress - Investing.com India

Mar 24, 2025
pulisher
Mar 24, 2025

Onconetix Announces Successful Clinical Validation Of Proclarix For Prostate Cancer In Danish Cohort - Nasdaq

Mar 24, 2025
pulisher
Mar 24, 2025

Onconetix reveals Proclarix’s clinical performance at EAU congress By Investing.com - Investing.com South Africa

Mar 24, 2025
pulisher
Mar 24, 2025

Onconetix Inc. Presents Promising Clinical Data for Proclarix® at 2025 EAU Congress - Nasdaq

Mar 24, 2025
pulisher
Mar 24, 2025

Revolutionary Prostate Cancer Test Cuts Unnecessary Biopsies by 22%, Shows 96% Detection Rate - Stock Titan

Mar 24, 2025
pulisher
Mar 21, 2025

Onconetix Inc (NASDAQ: ONCO): Blank Check On Growth? - Stocks Register

Mar 21, 2025
pulisher
Mar 19, 2025

Onconetix Announces New Clinical Data for its Innovative - GlobeNewswire

Mar 19, 2025
pulisher
Mar 19, 2025

Onconetix to Present Proclarix at EAU Congress 2025 - TipRanks

Mar 19, 2025
pulisher
Mar 19, 2025

Onconetix, Inc. to Present Proclarix Study Results at 2025 EAU Congress in Madrid - Nasdaq

Mar 19, 2025
pulisher
Mar 19, 2025

Groundbreaking 800-Patient Study Shows How Onconetix's Proclarix Test Prevents Unnecessary Prostate Biopsies - StockTitan

Mar 19, 2025
pulisher
Mar 19, 2025

ONCO stock plunges to 52-week low, touches $0.12 By Investing.com - Investing.com Australia

Mar 19, 2025
pulisher
Mar 18, 2025

ONCO stock plunges to 52-week low, touches $0.12 - Investing.com India

Mar 18, 2025
pulisher
Mar 03, 2025

Onconetix taps industry veteran as executive chairman amid CEO resignation - The Business Journals

Mar 03, 2025
pulisher
Feb 28, 2025

Onconetix names new executive chairman, appoints board member By Investing.com - Investing.com Australia

Feb 28, 2025
pulisher
Feb 28, 2025

Onconetix names new executive chairman, appoints board member - Investing.com India

Feb 28, 2025
pulisher
Feb 28, 2025

Onconetix Announces Leadership Changes and New Appointments - TipRanks

Feb 28, 2025
pulisher
Feb 28, 2025

Onconetix Says Ralph Schiess Resigns As Interim CEO And Chief Science Officer -February 28, 2025 at 05:35 pm EST - Marketscreener.com

Feb 28, 2025
pulisher
Feb 19, 2025

Onconetix secures new financing, appoints auditor, sees executive exit By Investing.com - Investing.com South Africa

Feb 19, 2025
pulisher
Feb 18, 2025

Onconetix secures new financing, appoints auditor, sees executive exit - Investing.com

Feb 18, 2025
pulisher
Feb 18, 2025

Onconetix Announces Promissory Note Agreement with Keystone - TipRanks

Feb 18, 2025
pulisher
Feb 05, 2025

Investing in Onconetix Inc (ONCO) might be an excellent idea, but the stock is currently overvalued/undervalued - US Post News

Feb 05, 2025
pulisher
Feb 04, 2025

Onconetix Inc (ONCO) Stock: A Year of Decreases and Increases - The InvestChronicle

Feb 04, 2025
pulisher
Feb 04, 2025

Daily Market Movement: Onconetix Inc (ONCO) Sees a 11.91 Increase, Closing at 0.61 - The Dwinnex

Feb 04, 2025
pulisher
Jan 29, 2025

Onconetix files to sell 50M shares of common stock for holders - MSN

Jan 29, 2025
pulisher
Jan 27, 2025

Stock market today: Allakos dropped by 76.37% whereas Onconetix jumped by 77.10% in early trading - Business Upturn

Jan 27, 2025
pulisher
Jan 27, 2025

Why Logility Supply Chain Solutions Shares Are Trading Higher By Over 23%; Here Are 20 Stocks Moving Premarket - Benzinga

Jan 27, 2025
pulisher
Jan 26, 2025

Onconetix faces Nasdaq delisting over share price rule - MSN

Jan 26, 2025
pulisher
Jan 24, 2025

Onconetix faces Nasdaq delisting over share price rule By Investing.com - Investing.com Nigeria

Jan 24, 2025
pulisher
Jan 23, 2025

Onconetix settles with IQVIA, adjusts accounts payable - MSN

Jan 23, 2025
pulisher
Jan 22, 2025

Onconetix settles with IQVIA, adjusts accounts payable By Investing.com - Investing.com Canada

Jan 22, 2025
pulisher
Jan 12, 2025

Pre-market Movers: ONCO, EYEN, SGMO, VSTM... - RTTNews

Jan 12, 2025
pulisher
Jan 03, 2025

Pre-market Movers: ONCO, COEP, NUVB, SPRC... - RTTNews

Jan 03, 2025
pulisher
Dec 31, 2024

Crude Oil Rises 1%; Sangamo Therapeutics Shares Plummet - Benzinga

Dec 31, 2024
pulisher
Dec 19, 2024

ONCO Stock Plummets to 52-Week Low at $0.37 Amid Market Struggles By Investing.com - Investing.com South Africa

Dec 19, 2024
pulisher
Dec 13, 2024

Onconetix files overdue quarterly report, addresses Nasdaq notice By Investing.com - Investing.com South Africa

Dec 13, 2024
pulisher
Dec 12, 2024

Onconetix files overdue quarterly report, addresses Nasdaq notice - Investing.com

Dec 12, 2024
pulisher
Dec 12, 2024

Onconetix, Inc. Announces Receipt of Notice from Nasdaq - GlobeNewswire

Dec 12, 2024
pulisher
Dec 12, 2024

Onconetix Resolves Nasdaq Compliance Issue After Late Q3 Filing - StockTitan

Dec 12, 2024
pulisher
Dec 11, 2024

ONCO stock touches 52-week low at $0.58 amid market challenges - Investing.com India

Dec 11, 2024
pulisher
Dec 10, 2024

Onconetix, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Dec 10, 2024
pulisher
Dec 10, 2024

Onconetix Inc. (ONCO) reports earnings - Quartz

Dec 10, 2024
pulisher
Dec 03, 2024

Onconetix amends forbearance agreement with Veru Inc. - Investing.com

Dec 03, 2024
pulisher
Dec 03, 2024

ONCO Stock Hits 52-Week Low at $0.6 Amid Market Challenges - Investing.com Nigeria

Dec 03, 2024

Onconetix Inc Stock (ONCO) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$67.48
price down icon 1.23%
$73.33
price down icon 0.15%
$31.79
price up icon 1.63%
$18.91
price down icon 7.58%
$92.01
price down icon 1.40%
biotechnology ONC
$264.32
price down icon 3.81%
Cap:     |  Volume (24h):